ESRRA facilitates hepatocellular carcinoma progression through transcriptional activation of PHF5A and serves as a potential therapeutic target of rosuvastatin

Cellular Signalling · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles